Pancreatic cancer uses the CCL2/CCL2 receptor (CCR2) axis to favor the mobilization and recruitment of inflammatory monocytes from the bone marrow to the tumor site to facilitate tumor growth 25, 34. Here, CCR2 is linked to pancreatic neoplasm.